查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1869627

坐骨神經痛治療市場規模、佔有率和趨勢分析報告：按產品、給藥途徑、分銷管道、地區和細分市場預測（2025-2033 年）

Sciatica Treatment Market Size, Share & Trends Analysis Report By Product, By Route of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

坐骨神經痛治療市場摘要

2024年全球坐骨神經痛治療市場規模估計為51.5億美元，預計2033年將達到107.1億美元。

預計從 2025 年到 2033 年，其複合年成長率將達到 8.40%。這一成長歸因於幾個關鍵因素，包括全球坐骨神經痛盛行率的上升、人口老化以及治療方法的進步。

由於醫療保健、患者照護和技術進步等領域的廣泛趨勢，坐骨神經痛治療市場正經歷顯著成長。其中一個關鍵促進因素是全球人口老化。隨著人們壽命的延長，坐骨神經痛等肌肉骨骼疾病的發生率也增加。世界衛生組織（世衛組織）根據2024年10月的估計，到2030年，全球六分之一的人口將達到或超過60歲。屆時，60歲及以上人口的比例將從2020年的10億增加到14億。預計到2050年，全球老年人口將翻倍（達21億）。預計2020年至2050年間，80歲及以上人口的數量將增加兩倍，達到4.26億，這將導致坐骨神經痛等慢性疾病的顯著增加。這一年齡層尤其容易罹患坐骨神經痛等慢性疾病。

隨著老年人口的成長，對有效治療方法坐骨神經痛相關慢性疼痛和行動障礙的需求也日益成長。這一趨勢在北美和歐洲等老齡化人口集中的地區尤為明顯。美國疾病管制與預防中心（CDC）已將肌肉骨骼疾病（MSD）列為美國成年人殘疾的主要原因之一。這些疾病包括背痛、關節損傷、肌腱炎和重複性勞損。它們可能導致暫時性或永久性殘疾，限制部分患者的行動能力。職業性肌肉骨骼疾病在勞動年齡人口中尤其普遍，這進一步加劇了對坐骨神經痛治療的需求。因此，這些地區的醫療保健系統正致力於開發和提供老年患者的專業治療方法，從而推動了市場擴張。

此外，幹細胞療法和富血小板血漿（PRP）注射等生物治療方法的發展，為更有針對性、更有效的坐骨神經痛治療提供了可能，尤其適用於椎間盤退化和神經損傷的病例。鑑於目前對PRP在慢性下背痛等疾病中潛在益處的研究不斷深入，這些治療方法未來完全有可能應用於坐骨神經痛的治療。同時，梅奧診所繼續提供傳統的坐骨神經痛治療方法，包括物理治療、藥物治療和硬膜外類固醇注射，這些都是治療坐骨神經痛的成熟治療方法。隨著新技術的不斷湧現，治療選擇將更加多樣化，從而為市場成長和創新創造機會。

另一個關鍵促進因素是人們對坐骨神經痛及其治療方案的認知不斷提高。隨著大眾對慢性疼痛和肌肉骨骼疾病的了解不斷加深，越來越多的患者開始尋求診斷和治療坐骨神經痛症狀。根據美國疾病管制與預防中心 (CDC) 2023 年美國美國患有慢性疼痛，其中 8.5% 的人患有嚴重影響日常生活或工作的慢性疼痛。慢性疼痛和嚴重影響日常生活的慢性疼痛是成年人就醫最常見的原因之一。醫療保健提供者也越來越強調早期療育的重要性，早期介入可以減少長期殘疾並改善患者的整體預後。

除了公眾意識的提高，人們也越來越重視改善治療的可近性，尤其是在發展中地區。亞太和拉丁美洲等地區醫療基礎設施的擴建，正在促進患者更容易獲得傳統和現代療法。例如，2023年3月，世界銀行核准了一項用於改善印度醫療基礎設施的資金，其中包括擴大脊椎護理服務，預計這將有助於滿足該地區日益成長的坐骨神經痛治療需求。

此外，遠端醫療服務和居家照護選擇的興起擴大了治療的覆蓋範圍，尤其惠及偏遠和醫療資源匱乏地區的病患。這種治療機會的增加，加上人們對該疾病認知的提高以及治療方法的進步，為未來幾年坐骨神經痛治療市場的持續擴張奠定了基礎。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 坐骨神經痛治療市場變數、趨勢與範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境分析
    • 產業分析—波特五力分析
    • PESTLE分析
    • 管道分析
    • 專利到期分析
    • 定價分析

第4章 坐骨神經痛治療市場：依產品分類的商業分析

  • 按產品分類的市場佔有率，2024 年和 2033 年
  • 產品細分儀表板
  • 2021-2033年按產品分類的市場規模、預測與趨勢分析
  • 止痛藥和非類固醇抗發炎藥
  • 神經病變疼痛藥物
  • 皮質類固醇
  • 其他

第5章 坐骨神經痛治療市場：依給藥途徑分類的業務分析

  • 按給藥途徑分類的市場佔有率，2024 年和 2033 年
  • 管理路線細分儀表板
  • 按管理途徑分類的市場規模、預測和趨勢分析，2021-2033年
  • 口服
  • 外用
  • 腸外/注射劑

第6章 坐骨神經痛治療市場：區域估算與趨勢分析

  • 2024 年及 2033 年區域市佔率分析
  • 區域市場概覽
  • 市場規模及預測趨勢分析（2021-2033）：
  • 北美洲
    • 按國家/地區分類，2021-2033 年
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭情勢

  • 參與者概覽
  • 企業市場分析
  • 公司分類
  • 策略規劃
  • 公司簡介/上市公司
    • AbbVie Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • Glenmark Pharmaceuticals Ltd.
    • Sorrento Therapeutics Inc.
    • Medtronic plc
    • Boston Scientific Corporation
    • Pfizer Inc.
    • Johnson &Johnson
    • Abbott Laboratories
Product Code: GVR-4-68040-769-7

Sciatica Treatment Market Summary

The global sciatica treatment market size was estimated at USD 5.15 billion in 2024 and is projected to reach USD 10.71 billion by 2033, growing at a CAGR of 8.40% from 2025 to 2033. This growth is attributed to several key factors, including the rising global prevalence of sciatica, aging populations, and advancements in treatment modalities.

The sciatica treatment market is experiencing significant growth, driven by several key factors that reflect broader trends in healthcare, patient care, and technological advancements. One of the primary drivers is the aging global population. As people live longer, the incidence of musculoskeletal conditions like sciatica increases. According to the World Health Organization, October 2024, By 2030, 1 in 6 people in the world will be aged 60 years or over. At this time, the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. By 2050, the world's population of people aged 60 years and older will double (2.1 billion). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million, with a significant rise in chronic conditions such as sciatica. This demographic is particularly vulnerable to chronic conditions like sciatica.

As the number of older adults rises, so does the demand for effective treatment options to address the chronic pain and mobility issues associated with sciatica. This trend is especially noticeable in regions like North America and Europe, where a significant proportion of the population is aging. The Centers for Disease Control and Prevention (CDC) has identified musculoskeletal disorders (MSDs) as a leading cause of disability among U.S. adults. These disorders encompass conditions such as back pain, joint injuries, tendinitis, and repetitive strain. They can cause temporary or even permanent disability, leaving some individuals unable to move around easily. Work-related MSDs are particularly prevalent among people during their working years, contributing to a rise in demand for sciatica treatments. Consequently, healthcare systems in these regions are focusing on developing and providing specialized treatment options for older patients, thus contributing to market expansion.

Furthermore, the development of biologic treatments, such as stem cell therapy and platelet-rich plasma (PRP) injections, offers potential for more targeted and effective management of sciatica, especially in cases involving disc degeneration or nerve damage. Given the rise in research on PRP's potential benefits for conditions like chronic lower back pain, it is plausible that treatments like these could be explored for sciatica in the future. In the same period, Mayo Clinic continued to offer more conventional treatments for sciatica, such as physical therapy, medications, and injections (like epidural steroids), which have been well-established as effective for managing sciatica-related pain. As new technologies continue to emerge, treatment options will diversify, creating opportunities for market growth and innovation.

Another important driver is the increasing awareness of sciatica and its available treatment options. As public awareness around chronic pain conditions and musculoskeletal disorders rises, more patients are seeking diagnosis and management for sciatica symptoms. According to the Centers for Disease Control and Prevention (CDC), data from the National Health Interview Survey in 2023 revealed that 24.3% of U.S. adults had chronic pain, and 8.5% had high-impact chronic pain that frequently limited life or work activities. Chronic pain and high-impact chronic pain are among the most common reasons adults seek medical care. Healthcare providers are also increasingly emphasizing early intervention, which helps reduce long-term disability and improves overall patient outcomes.

In addition to growing awareness, there is a greater focus on improving access to treatment, especially in developing regions. The expansion of healthcare infrastructure in regions like Asia Pacific and Latin America is facilitating greater access to both traditional and modern treatment options. For example, in March 2023, the World Bank approved funding to improve healthcare infrastructure in India, including the expansion of spine care services. This is expected to support a greater demand for sciatica treatments in the region.

Furthermore, the increasing availability of telemedicine services and home care options is also allowing for broader access to treatment, particularly for patients in remote or underserved areas. This growing accessibility, combined with higher awareness and advancements in treatment methods, positions the sciatica treatment market for continued expansion in the coming years.

Global Sciatica Treatment Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global sciatica treatment market report based on product, route of administration, distribution channel, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Analgesics & NSAIDs
  • Neuropathic Pain Agents
  • Corticosteroids
  • Others
  • Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)
  • Oral
  • Topical
  • Parenteral / Injectable
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Retail Pharmacy
  • Hospital Pharmacy
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Route of Administration
    • 1.2.3. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Sciatica Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis
    • 3.3.4. Patent Expiry Analysis
    • 3.3.5. Pricing Analysis

Chapter 4. Sciatica Treatment Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2033
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Analgesics & NSAIDs
    • 4.4.1. Analgesics & NSAIDs Market, 2021 - 2033 (USD Million)
  • 4.5. Neuropathic Pain Agents
    • 4.5.1. Neuropathic Pain Agents Market, 2021 - 2033 (USD Million)
  • 4.6. Corticosteroids
    • 4.6.1. Corticosteroids Market, 2021 - 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. Sciatica Treatment Market: Route of Administration Business Analysis

  • 5.1. Route of Administration Market Share, 2024 & 2033
  • 5.2. Route of Administration Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2021 to 2033 (USD Million)
  • 5.4. Oral
    • 5.4.1. Oral Market, 2021 - 2033 (USD Million)
  • 5.5. Topical
    • 5.5.1. Topical Market, 2021 - 2033 (USD Million)
  • 5.6. Parenteral / Injectable
    • 5.6.1. Parenteral / Injectable Market, 2021 - 2033 (USD Million)

Chapter 6. Sciatica Treatment Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 6.4. North America
    • 6.4.1. North America Sciatica Treatment Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Target Disease Prevalence
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Reimbursement Framework
      • 6.4.2.5. U.S. Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Target Disease Prevalence
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Reimbursement Framework
      • 6.4.3.5. U.S. Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Target Disease Prevalence
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. Reimbursement Framework
      • 6.4.4.5. Mexico Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Target Disease Prevalence
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Reimbursement Framework
      • 6.5.2.5. Uk Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Target Disease Prevalence
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Reimbursement Framework
      • 6.5.3.5. Germany Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Target Disease Prevalence
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Reimbursement Framework
      • 6.5.4.5. France Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Target Disease Prevalence
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Reimbursement Framework
      • 6.5.5.5. Italy Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Target Disease Prevalence
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Reimbursement Framework
      • 6.5.6.5. Spain Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Target Disease Prevalence
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Reimbursement Framework
      • 6.5.7.5. Denmark Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Target Disease Prevalence
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Reimbursement Framework
      • 6.5.8.5. Sweden Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Target Disease Prevalence
      • 6.5.9.3. Regulatory Framework
      • 6.5.9.4. Reimbursement Framework
      • 6.5.9.5. Norway Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Target Disease Prevalence
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Reimbursement Framework
      • 6.6.2.5. Japan Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Target Disease Prevalence
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Reimbursement Framework
      • 6.6.3.5. China Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Target Disease Prevalence
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Reimbursement Framework
      • 6.6.4.5. India Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Target Disease Prevalence
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Reimbursement Framework
      • 6.6.5.5. Australia Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.6. South Korea
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Target Disease Prevalence
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Reimbursement Framework
      • 6.6.6.5. South Korea Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Target Disease Prevalence
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Reimbursement Framework
      • 6.6.7.5. Thailand Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Target Disease Prevalence
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Reimbursement Framework
      • 6.7.2.5. Japan Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Target Disease Prevalence
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Reimbursement Framework
      • 6.7.3.5. China Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Middle East and Africa
    • 6.8.1. Middle East and Africa Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Target Disease Prevalence
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Reimbursement Framework
      • 6.8.2.5. South Africa Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Target Disease Prevalence
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Reimbursement Framework
      • 6.8.3.5. Saudi Arabia Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Target Disease Prevalence
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. Reimbursement Framework
      • 6.8.4.5. UAE Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Target Disease Prevalence
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Reimbursement Framework
      • 6.8.5.5. Kuwait Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. AbbVie Inc.
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Disease Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Teva Pharmaceutical Industries Ltd.
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Disease Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Sun Pharmaceutical Industries Ltd.
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Disease Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Glenmark Pharmaceuticals Ltd.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Sorrento Therapeutics Inc.
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Medtronic plc
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Boston Scientific Corporation
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Pfizer Inc.
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Johnson & Johnson
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. Abbott Laboratories
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global sciatica treatment market, by region, 2021 - 2033 (USD Million)
  • Table 4 Global sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 5 Global sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 6 Global sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 7 North America sciatica treatment market, by country, 2021 - 2033 (USD Million)
  • Table 8 North America sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 9 North America sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 10 North America sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 11 US sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 12 US sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 13 Canada sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 14 Canada sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 15 Canada sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 16 Mexico sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 17 Mexico sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 18 Mexico sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 19 Europe sciatica treatment market, by country, 2021 - 2033 (USD Million)
  • Table 20 Europe sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 21 Europe sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 22 Europe sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 23 UK sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 24 UK sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 25 UK sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 26 Germany sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 27 Germany sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 28 Germany sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 29 France sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 30 France sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 31 France sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 32 Italy sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 33 Italy sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 34 Italy sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 35 Spain sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 36 Spain sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 37 Spain sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 38 Norway sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 39 Norway sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 40 Norway sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 41 Denmark sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 42 Denmark sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 43 Denmark sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 44 Sweden sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 45 Sweden sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 46 Sweden sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific sciatica treatment market, by country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 51 Japan sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 52 Japan sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 53 Japan sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 54 China sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 55 China sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 56 China sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 57 India sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 58 India sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 59 India sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 60 Australia sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 61 Australia sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 62 Australia sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 63 South Korea sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 64 South Korea sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 65 South Korea sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 66 Thailand sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 67 Thailand sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 68 Thailand sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 69 Latin America sciatica treatment market, by country, 2021 - 2033 (USD Million)
  • Table 70 Latin America sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 71 Latin America sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 72 Latin America sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 73 Brazil sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 74 Brazil sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 75 Brazil sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 76 Argentina sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 77 Argentina sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 78 Argentina sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 79 Middle East & Africa Sciatica treatment market, by country, 2021 - 2033 (USD Million)
  • Table 80 Middle East & Africa sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 81 Middle East & Africa sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 82 Middle East & Africa sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 83 South Africa sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 84 South Africa sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 85 South Africa sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 89 UAE sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 90 UAE sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 91 UAE sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 92 Kuwait sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 93 Kuwait sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 94 Kuwait sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Sciatica treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Therapeutic approach and product outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Sciatica treatment market dynamics
  • Fig. 12 Sciatica treatment market: Porter's five forces analysis
  • Fig. 13 Sciatica treatment market: PESTLE analysis
  • Fig. 14 Product market, 2021 - 2033 (USD Million)
  • Fig. 15 Analgesics & NSAIDs market, 2021 - 2033 (USD Million)
  • Fig. 16 Neuropathic Pain Agents market, 2021 - 2033 (USD Million)
  • Fig. 17 Corticosteroids market, 2021 - 2033 (USD Million)
  • Fig. 18 Others market, 2021 - 2033 (USD Million)
  • Fig. 19 Route of Administration market, 2021 - 2033 (USD Million)
  • Fig. 20 Oral market, 2021 - 2033 (USD Million)
  • Fig. 21 Topical market, 2021 - 2033 (USD Million)
  • Fig. 22 Parenteral / Injectable market, 2021 - 2033 (USD Million)
  • Fig. 23 Distribution Channel market, 2021 - 2033 (USD Million)
  • Fig. 24 Retail Pharmacy market, 2021 - 2033 (USD Million)
  • Fig. 25 Hospital Pharmacy market, 2021 - 2033 (USD Million)
  • Fig. 26 Others market, 2021 - 2033 (USD Million)
  • Fig. 27 Sciatica treatment market revenue, by region
  • Fig. 28 Regional marketplace: Key takeaways
  • Fig. 29 North America sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 30 U.S. country dynamics
  • Fig. 31 U.S. sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 32 Canada country dynamics
  • Fig. 33 Canada sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 34 Mexico country dynamics
  • Fig. 35 Mexico sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 36 Europe sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 37 UK country dynamics
  • Fig. 38 UK sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 39 Germany country dynamics
  • Fig. 40 Germany sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 41 France country dynamics
  • Fig. 42 France sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 43 Italy country dynamics
  • Fig. 44 Italy sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 45 Spain country dynamics
  • Fig. 46 Spain sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 47 Norway country dynamics
  • Fig. 48 Norway sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 49 Sweden country dynamics
  • Fig. 50 Sweden sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 51 Denmark country dynamics
  • Fig. 52 Denmark sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 53 Asia Pacific sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 54 Japan country dynamics
  • Fig. 55 Japan sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 56 China country dynamics
  • Fig. 57 China sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 58 India country dynamics
  • Fig. 59 India sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 60 Australia country dynamics
  • Fig. 61 Australia sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 62 South Korea country dynamics
  • Fig. 63 South Korea sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 64 Thailand country dynamics
  • Fig. 65 Thailand sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 66 Latin America sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 67 Brazil country dynamics
  • Fig. 68 Brazil sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 69 Argentina country dynamics
  • Fig. 70 Argentina sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 71 MEA sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 72 South Africa country dynamics
  • Fig. 73 South Africa sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 74 Saudi Arabia country dynamics
  • Fig. 75 Saudi Arabia sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 76 UAE country dynamics
  • Fig. 77 UAE sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 78 Kuwait country dynamics
  • Fig. 79 Kuwait sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 80 Company categorization
  • Fig. 81 Company market position analysis
  • Fig. 82 Strategic framework